Pharmarise Holdings Corp. (2796) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Pharmarise Holdings Corp. (2796:JPX), powered by AI.

Current Price
¥498
P/E Ratio
-15.3
Market Cap
5.6B
Sector
Healthcare
What is the Pharmarise Holdings Corp. stock price forecast?

Pharmarise Holdings Corp. is currently trading at ¥498. View real-time AI analysis on Alpha Lenz.

What is Pharmarise Holdings Corp. insider trading activity?

View the latest insider trading data for Pharmarise Holdings Corp. on Alpha Lenz.

What is Pharmarise Holdings Corp.'s P/E ratio?

Pharmarise Holdings Corp.'s P/E ratio is -15.3.

Pharmarise Holdings Corp.

JPX · 2796
¥498-2(-0.40%)Market closedJPX regular session 09:00–15:00 JST
Ask about Pharmarise Holdings Corp.'s future dividend policy...
Alpha Chat Insight

Pharmarise Holdings Corp. trades at a P/E of -15.3 (undervalued) with modest ROE of -5.2%.

Ask for details

Company Overview

Pharmarise Holdings Corp. operates as a healthcare and pharmaceutical company, predominantly engaged in the management of pharmacies across Japan. The primary function of Pharmarise Holdings Corp. is to provide comprehensive pharmaceutical services, including the dispensing of medications, health consultations, and pharmaceutical management. As a leading player in the health services sector, the company strives to enhance community wellness by improving access to necessary medicines and offering professional healthcare advice. Pharmarise Holdings Corp. significantly impacts the healthcare industry by ensuring that communities receive timely and accurate pharmaceutical care. By operating a network of pharmacies, the company plays a critical role in the retail pharmaceutical market, aiding in the distribution of prescription and over-the-counter medications. Pharmarise Holdings Corp.’s market role is vital as it enhances the quality of healthcare delivery within its operational regions, contributing to the overall health infrastructure. As part of the wider healthcare system in Japan, the company has established a significant presence, enabling it to influence patient care standards and pharmacy operations effectively.

CEOMr. Toshimichi Ohno
SectorHealthcare
IndustryPharmaceutical Retailers
Employees2,039

Company Statistics

FY 2025

Profile

¥5,638,140,366Market Cap
¥63,508,000,000Revenue
0.00Shares Out
2,039Employees

Margins

14.12%Gross
2.81%EBITDA
0.46%Operating
0.01%Pre-Tax
-0.60%Net

Valuation

-15.32P/E
0.82P/B
0.09EV/Sales
8.42EV/EBITDA
9.26P/FCF

Growth (CAGR)

7.16%Rev 3Yr
4.47%Rev 5Yr
-42.18%Op Inc 3Yr
-22.25%Op Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-1.24%ROA
-5.17%ROE
0.61%ROIC

Financial Health

¥4,911,000,000Cash & Cash Equivalents
¥20,097,000,000Net Debt
361.60%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Pharmarise Holdings Corp. (ticker: 2796) is a company listed on JPX in the Healthcare sector (Pharmaceutical Retailers). It has approximately 2,039 employees. Market cap is $5.6B.

The current price is 498 with a P/E ratio of -15.32x and P/B of 0.82x.

ROE is -5.17% and operating margin is 0.46%. Annual revenue is $63.5B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Pharmarise Holdings Corp. (2796) Stock Forecast 2026 ¥498 — Price, Financials & Analyst Targets | Alpha Lenz